Publication | Open Access
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations
35
Citations
15
References
2022
Year
In contrast to what was observed in the context of chemotherapy-free ICI-based regimens, baseline BMI does not affect clinical outcomes from chemoimmunotherapy combinations in patients with advanced NSCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1